Skip to main navigation Skip to search Skip to main content

ATIM-47. NIVOLUMAB VS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA: EXPLORATORY ANALYSIS OF MGMT METHYLATION STATUS AND BASELINE CORTICOSTEROID USE

Michael Weller, David Reardon, Alba Brandes, John Sampson, Paul Mulholland, Antje Wick, Joachim Baehring, Manmeet Ahluwalia, Patrick Roth, Oliver Bähr, Surasak Phuphanich, Juan Sepulveda, Paul de Souza, Solmaz Sahebjam, Von Potter, Kay Tatsuoka, Corina Taitt, Ricardo Zwirtes, Antonio Omuro, Michael Lim

Research output: Contribution to conferencePresentation

Original languageAmerican English
DOIs
StatePublished - Nov 11 2019
EventNeuro-oncology -
Duration: Nov 11 2019 → …

Conference

ConferenceNeuro-oncology
Period11/11/19 → …

Disciplines

  • Medicine and Health Sciences
  • Oncology
  • Internal Medicine

Cite this